about
Clostridium difficile phages: still difficult?An update on antibody-based immunotherapies for Clostridium difficile infectionPleiotropic role of the RNA chaperone protein Hfq in the human pathogen Clostridium difficileInitiation of sporulation in Clostridium difficile: a twist on the classic modelImmunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliCBiofilm formation of Clostridium difficile and susceptibility to Manuka honey.Dysbiosis and Immune Dysregulation in Outer Space.Clostridium difficile colitis: pathogenesis and host defenceSociomicrobiology and Pathogenic BacteriaClostridium difficile recurrent infection: possible implication of TA systems.Acyldepsipeptide antibiotics as a potential therapeutic agent against Clostridium difficile recurrent infections.The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms and planktonic cells.The spore-associated protein BclA1 affects the susceptibility of animals to colonization and infection by Clostridium difficile.Community-acquired infection with hypervirulent Clostridium difficile isolates that carry different toxin and antibiotic resistance loci: a case report.Analysis of Clostridium difficile biofilms: imaging and antimicrobial treatment.Lauric Acid Is an Inhibitor of Clostridium difficile Growth in Vitro and Reduces Inflammation in a Mouse Infection Model.Treatment of recurrent Clostridium difficile colitis: a narrative review.Biofilm: Remodeling Metabolism and Cell Surface to Build a Sparse and Heterogeneously Aggregated ArchitectureAntimicrobial Effect of Asiatic Acid Against Is Associated With Disruption of Membrane Permeability
P2860
Q21131097-342E7F9E-2DD4-44E5-BE6C-F68FC5EE670DQ26740788-1D85D3C0-F4B9-4EB7-98E4-F23288ED2A6DQ34056874-5C647407-46E0-48E3-A3A5-8AB0FA3CECB5Q34306985-248D691F-76FD-4D08-BE3B-99F53F17D3F7Q34512085-D30187E9-FBDF-4BD0-82ED-A5B6A29091A3Q35237006-DC91B9C3-997C-4B0B-95AF-6F1D94695FD4Q35630294-A8822D72-F190-4E07-B276-F8F6093FA623Q36116428-469BD114-D6AD-44FB-B6FD-BFBF3BF83A6AQ37035989-19A4078C-980D-4209-9A4D-1F6912F3364AQ38600111-83539987-9042-4CFE-A88F-AAC17D687E93Q38829284-90A7F972-3453-4E03-83F5-7990E4507333Q40647464-F46DEC6F-C42E-448F-AB4B-E979BFDF0FB6Q42219908-58887570-6342-44E8-9B84-A468DC84A0ABQ46793647-383F177B-F234-41A5-A435-A617C9E5FC76Q47446946-8F5BABDA-F207-49A3-BA4A-D9B5014292FEQ49368088-4EAF33C6-4826-4FCB-BBBE-847D5B6F76D7Q50285268-A88A5768-1172-46B9-9259-6A9B270C5BD6Q58746416-C0F387E2-E99B-433D-B484-28B6C22A8245Q58758967-894E6C53-F92C-4732-B41E-FFE923CAA888
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Biofilm formation by Clostridium difficile.
@en
type
label
Biofilm formation by Clostridium difficile.
@en
prefLabel
Biofilm formation by Clostridium difficile.
@en
P2860
P356
P1433
P1476
Biofilm formation by Clostridium difficile
@en
P2093
Meera Unnikrishnan
Tanja Dapa
P2860
P304
P356
10.4161/GMIC.25862
P577
2013-07-25T00:00:00Z